PCM
INSM icon

Penserra Capital Management’s Insmed INSM Stock Holding History

Penserra Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,635
Closed -$72K – 1445
2021
Q3 		$72K Buy
2,635
+15
+0.6% +$394 ﹤0.01% 934
2021
Q2 		$74K Buy
2,620
+290
+12% +$8.61K ﹤0.01% 888
2021
Q1 		$79K Sell
2,330
-5
-0.2% -$191 ﹤0.01% 731
2020
Q4 		$77K Buy
2,335
+1,469
+170% +$53.7K ﹤0.01% 625
2020
Q3 		$27K Buy
+866
New +$24.9K ﹤0.01% 701

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Penserra Capital Management's INSM Position: Q4 2021 in Review

Penserra Capital Management sold out of Insmed (INSM) in Q4 2021, closing a stake of 2,635 shares — an estimated $72K sold.

Penserra Capital Management first reported a position in INSM in Q3 2020 and held it in 5 quarters. The position peaked at $79K in Q1 2021. 214 funds tracked by Wall St. Rank hold INSM as of Q4 2021.

  • Penserra Capital Management reported no remaining Insmed position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 2,635 Insmed shares in Q4 2021, an estimated $72K.
  • Penserra Capital Management first reported a position in Insmed in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Insmed position peaked at $79K in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Insmed as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.